Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Miller

Showing results (131-140 of 349) with videos related to

Pageof 35
Sort By:
Artery|January 1, 1981
Oxandrolone and plasma triglyceride reduction: effect on triglyceride-rich and high density lipoproteinsT Hara, J P Miller, A M Gotto, et al.
Thrombosis and Haemostasis|May 25, 2001
Tamoxifen increases von Willebrand factor in women who underwent breast cancer surgeryA D Blann, A D Baildam, A Howell, et al.
Proceedings of the Royal Society of Medicine|December 1, 1970
Iron overload in haemochromatosisI W Dymock, J P Miller, B E Godfrey, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Refuting the UGDP conclusion that insulin treatment does not prevent vascular complications in diabetesC Kilo, J R Williamson, S C Choi, et al.
Survey of Ophthalmology|November 1, 1980
Risk factors favoring the development of glaucomatous visual field loss in ocular hypertensionM A Kass, W M Hart, M Gordon, et al.
Atherosclerosis|August 1, 1995
Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular diseaseA D Blann, S R Maxwell, G Burrows, et al.
Journal of Neurophysiology|August 1, 1983
Factors that control amplitude of EPSPs in dendritic neuronsA Lev-Tov, J P Miller, R E Burke, et al.
The International Journal of the Addictions|April 1, 1982
Nonpsychiatric predictors of narcotic dependence: a prospective study with a 5-year follow-upB Y Whitman, J L Croughan, J P Miller, et al.
The Journal of Clinical Psychiatry|September 1, 1982
Psychiatric diagnosis and prediction of drug and alcohol dependenceJ L Croughan, J P Miller, A Matar, et al.
JAMA|January 5, 1979
Insulin treatment and diabetic vascular complicationsC Kilo, J R Williamson, S C Choi, et al.
Pageof 35

Showing results (131-140 of 349) with videos related to

Sort By:
Pageof 35
Artery|January 1, 1981
Oxandrolone and plasma triglyceride reduction: effect on triglyceride-rich and high density lipoproteinsT Hara, J P Miller, A M Gotto, et al.
Thrombosis and Haemostasis|May 25, 2001
Tamoxifen increases von Willebrand factor in women who underwent breast cancer surgeryA D Blann, A D Baildam, A Howell, et al.
Proceedings of the Royal Society of Medicine|December 1, 1970
Iron overload in haemochromatosisI W Dymock, J P Miller, B E Godfrey, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Refuting the UGDP conclusion that insulin treatment does not prevent vascular complications in diabetesC Kilo, J R Williamson, S C Choi, et al.
Survey of Ophthalmology|November 1, 1980
Risk factors favoring the development of glaucomatous visual field loss in ocular hypertensionM A Kass, W M Hart, M Gordon, et al.
Atherosclerosis|August 1, 1995
Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular diseaseA D Blann, S R Maxwell, G Burrows, et al.
Journal of Neurophysiology|August 1, 1983
Factors that control amplitude of EPSPs in dendritic neuronsA Lev-Tov, J P Miller, R E Burke, et al.
The International Journal of the Addictions|April 1, 1982
Nonpsychiatric predictors of narcotic dependence: a prospective study with a 5-year follow-upB Y Whitman, J L Croughan, J P Miller, et al.
The Journal of Clinical Psychiatry|September 1, 1982
Psychiatric diagnosis and prediction of drug and alcohol dependenceJ L Croughan, J P Miller, A Matar, et al.
JAMA|January 5, 1979
Insulin treatment and diabetic vascular complicationsC Kilo, J R Williamson, S C Choi, et al.
Pageof 35